Improving insulin treatment
ISRCTN | ISRCTN79558333 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN79558333 |
Secondary identifying numbers | N0203125673 |
- Submission date
- 30/09/2004
- Registration date
- 30/09/2004
- Last edited
- 26/07/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Mark Daly
Scientific
Scientific
Royal Devon & Exeter Hospital (Wonford)
Barrack Road
Exeter
EX2 5DW
United Kingdom
Phone | +44 (0)1392 403086 |
---|---|
M.E.Daly@exeter.ac.uk |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use contact details to request a participant information sheet |
Scientific title | Improving insulin treatment |
Study objectives | Is post-prandial targeting of glucose better than pre-prandial targeting when using insulin glargine and novorapid in combination? |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Nutritional, Metabolic, Endocrine: Diabetes |
Intervention | Randomised Controlled Trial 1. Glargine/novorapid/fasting and post-prandial titration of insulin doses 2. Glargine/novorapid/fasting and pre-prandial titration of insulin doses 30 patients with Type I diabetes will be recruited via clinicians (medical and nursing staff) within the Exeter Diabetes Centre, fully informed and having given written consent. Prior to randomisation, each patient will wear a continuous glucose monitor for 72 hours and have blood samples taken for HbAlc. Each patient will then be randomised to receive one of two treatments. One group will be transferred to the intervention (glargine/novorapid/fasting and post-prandial titration of insulin doses) and followed up for three months. The second group will be randomised to the same insulin regimen but insulin doses will be titrated against pre-prandial and fasting measurements. Both groups will undergo a similar protocol of specialist nurse contact and intensification of their glycaemic control. 72 hours of continuous glucose monitoring system (CGMS) will take place before treatment and at the end of the three month period. Food and exercise diaries will be kept for these periods and patients will be asked to replicate the initial pattern of food and exercise for the second period. |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Applicable |
Drug / device / biological / vaccine name(s) | Insulin |
Primary outcome measure | To see if adjusting pre-prandial insulin on the basis of post-prandial measurements is feasible as a clinical approach in the routine clinical situation and to explore the possibility that it might improve overall diabetes control. |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 22/04/2003 |
Completion date | 22/11/2003 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Both |
Target number of participants | 30 |
Key inclusion criteria | 1. Type 1 diabetes 2. >2 years duration 3. Clinical decision for glargine/novorapid therapy independently of the study 4. Fully informed and consented |
Key exclusion criteria | Does not match inclusion criteria |
Date of first enrolment | 22/04/2003 |
Date of final enrolment | 22/11/2003 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Royal Devon & Exeter Hospital (Wonford)
Exeter
EX2 5DW
United Kingdom
EX2 5DW
United Kingdom
Sponsor information
Department of Health
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Website | http://www.dh.gov.uk/Home/fs/en |
---|
Funders
Funder type
Hospital/treatment centre
Royal Devon and Exeter NHS Trust (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Editorial Notes
26/07/2016: No publications found, verifying study status with principal investigator.